Author Correction: Identification of neoantigens for individualized therapeutic cancer vaccines

Franziska Lang^{1

2}, Barbara Schrörs¹, Martin Löwer¹, Özlem Türeci³, Ugur Sahin^{4

5}

Affiliations

¹ TRON Translational Oncology, Mainz, Germany.
² Faculty of Biology, Johannes Gutenberg University Mainz, Mainz, Germany.
³ BioNTech, Mainz, Germany.
⁴ BioNTech, Mainz, Germany. sahin@uni-mainz.de.
⁵ University Medical Center, Johannes Gutenberg University, Mainz, Germany. sahin@uni-mainz.de.

Published Erratum

Franziska Lang et al. Nat Rev Drug Discov. 2024 Feb.

. 2024 Feb;23(2):156.

doi: 10.1038/s41573-023-00873-5.

Franziska Lang^{1

2}, Barbara Schrörs¹, Martin Löwer¹, Özlem Türeci³, Ugur Sahin^{4

5}

¹ TRON Translational Oncology, Mainz, Germany.
² Faculty of Biology, Johannes Gutenberg University Mainz, Mainz, Germany.
³ BioNTech, Mainz, Germany.
⁴ BioNTech, Mainz, Germany. sahin@uni-mainz.de.
⁵ University Medical Center, Johannes Gutenberg University, Mainz, Germany. sahin@uni-mainz.de.

No abstract available

Erratum for

Identification of neoantigens for individualized therapeutic cancer vaccines.
Lang F, Schrörs B, Löwer M, Türeci Ö, Sahin U. Lang F, et al. Nat Rev Drug Discov. 2022 Apr;21(4):261-282. doi: 10.1038/s41573-021-00387-y. Epub 2022 Feb 1. Nat Rev Drug Discov. 2022. PMID: 35105974 Free PMC article. Review.